The fifth ILD Summit, hosted by Boehringer Ingelheim, took place in the UAE, a gathering where the world’s leading specialists in lung health came together to shape the future of care. The question that came after was simple: what happens inside a summit that brings together pulmonologists, rheumatologists and radiologists in the region?
Dr Marjan Maghami, medical director for India, the Middle East, Turkey and Africa at Boehringer Ingelheim, was asked to share her ten insights that defined this year’s discussions.
1. ILD is a universe of diseases
It covers more than two hundred disorders that scar the lungs and make breathing harder with time. The scarring in the lungs caused by ILD is often permanent and cannot be reversed.
2. IPF leads the statistics
Idiopathic pulmonary fibrosis affects roughly three million people globally, with substantial increase in incidence with age.
3. Subtle symptoms, serious meaning
Cough, fatigue and breathlessness are early markers often overlooked. Symptoms of ILD can develop slowly over months or years, but in some cases, they may appear suddenly, especially in acute forms of the disease.
4. Early diagnosis saves time
When doctors act early, they can slow the progression of the disease, help manage symptoms, and help improve the quality of life.
5.
Continue Reading on The National UAE
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.